Our chief scientific officer Dr Marie O’Brien is featured in the April/May edition of Laboratory News discussing ReNewVax’s RVX-001 pneumococcal vaccine program. 

In the article, Dr O’Brien explores how we are deploying novel platform technology for vaccine design based on the concept of reverse vaccinology to create the first universal vaccine for streptococcus pneumoniae. 

The feature can be read in full here.